A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector)
Clinical trial NCT04341389 · COMPLETED
Trial details
- NCT number
- NCT04341389
- Sponsor
- Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-12
- Primary completion
- 2020-11-30
- Enrollment
- 508
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.